Tobias Hohenauer, Carola Berking, Andreas Schmidt, Sebastian Haferkamp, Daniela Senft, Claudia Kammerbauer, Sabine Fraschka, Saskia Anna Graf, Martin Irmler, Johannes Beckers, Michael Flaig, Achim Aigner, Sabrina Höbel, Franziska Hoffmann, Heiko Hermeking, Simon Rothenfusser, Stefan Endres, Thomas Ruzicka and Robert Besch The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival EMBO Molecular Medicine 5
Version of Record online: 13 MAY 2013 | DOI: 10.1002/emmm.201201862
Brn3a, a POU family transcription factor normally involved in neuronal development, is reported here to promote melanoma survival by playing a role in cell cycle progression. Targeting Brn3a and its regulated genes could offer therapeutic value.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field